SANN.S (SANN.S) News
Track canonical SquawkNews coverage tagged to SANN.S, SANN.S. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
Santhera Pharma H1 revenue rises 101% on AGAMREE sales; 2026 guidance kept at CHF 80-90 mln
Santhera said H1 revenue rose 101% year-on-year, with product sales up 48% and net loss narrowing to CHF 21.5 mln from CHF 38.8 mln. It kept 2026 revenue guidance at CHF 80-90 mln and expects product sales to grow by mor
EARNINGS | Sep 30, 2026, 05:11 AM UTC
M
Santhera names Orlando Oliveira CEO; Marc Clausse chief commercial officer
Santhera named Orlando Oliveira chief executive officer in July 2026, replacing Dario Eklund, and Marc Clausse joined as chief commercial officer in June 2026, taking over from Geert Jan van Daal. Dr. Srishti Gupta was e
EQUITY | Sep 30, 2026, 05:02 AM UTC